Intellia Therapeutics is trading 5% up today at $11.32 as a broad biotech rally lifts the sector.

  • The move appears driven by wider industry momentum, with the XBI ETF rising 2.02% during regular trading.
  • Sector sentiment is being supported by strong earnings and a series of positive biotech news developments.
  • No company-specific catalyst was identified for the move, suggesting the gain is tied to the overall sector strength.